Virtual Mentor spoke with Dr. Stephen Epstein of Harvard Medical School about the Massachusetts ban and what other communities can learn from one state's experience.
The Supreme Court’s ruling in Riegel v. Medtronic, Inc., may prevent consumers injured by medical devices that have FDA premarket approval from receiving compensation.
Physicians who base end-of-life care decisions for patients on their own preferences may offer less treatment than the patients themselves would have wanted.
Medicine, a high-energy consumer and generator of much waste—some of it toxic—must scale back the health care enterprise in the interest of preserving a livable environment.
Taking care of patients whose cultures, belief systems, and family hierarchy structures differ from those on which many U.S. laws and regulations involves strategies—particularly regarding end-of-life care and surrogate decision making.